Nasal drug delivery is fast becoming a preferred alternative to some conventional dosage forms such as oral or parenteral dosage forms.
Aptar Pharma offers a full range of Orally Inhaled and Nasal Drug Product (OINDP) systems and services to support this growing sector. Aptar Pharma specializes in offering the most advanced intranasal drug delivery services including everything from manufacture, formulation development all the way through to clinical and commercial product manufacturing.
Aptar Pharma’s Unidose and Bidose nasal spray systems can reliably delivery precise nasal drug dosing in a simple, easy to use, safe, and portable package for both systemic and local administration with rapid onset capabilities. Also offering multi-dose preservative free nasal spray systems, PureHale® technology and bag-on-valve options means Aptar Pharma has the widest range of nasal delivery systems found anywhere.
Ideal for new drug formulations as well as for drug repositioning and life-cycle management strategies, nasal drug delivery routes can mean differentiated products with enhanced patient benefits. From emergency use applications to chronic treatment options, nasal spray and nasal powder drug delivery is a strategic option for many of today’s drug products.